The US Food and Drug Administration (FDA) frequently stress the
importance of enrolling diverse patient populations in clinical trials
conducted to support product applications. Meg Egan Auderset
at Clarivate Analytics discusses the multiple recommendations
from FDA and how sponsors can meet agency expectations to get
products approved.
FDA Guidance Recommends Diversity in Clinical Trials, but Can’t Require It
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
Journal For Clinical Studies © 2023, All Rights Reserved – Powered by Teksyte